Literature DB >> 35348941

A novel variation in RANBP2 associated with infection-triggered familial acute necrotizing encephalopathy.

Yu Hu1, Zhen Tian2, Bin Zhao2, Chuansheng Dong3, Lihua Cao4.   

Abstract

Acute necrotizing encephalopathy (ANE) is a rapidly progressive encephalopathy occurring in otherwise healthy children after common viral infections. The condition presents as a spectrum of symptoms ranging from infections to seizures and coma, with the potential to cause long-term neurocognitive impairment or death. Familial and recurrent ANE is referred to as ANE1. A four-generation Chinese family with ANE1 was recruited for genetic analysis. A novel missense variation, c.9041A > G, p.(Glu3014Gly) in RANBP2 was identified in this family. This study is the first to identify a novel variation in RANBP2 in a Chinese family with ANE1.
© 2022. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Acute necrotizing encephalopathy; RANBP2; Variation; Whole-exome sequencing

Mesh:

Substances:

Year:  2022        PMID: 35348941     DOI: 10.1007/s10072-022-06033-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  8 in total

1.  Differential loss of prolyl isomerase or chaperone activity of Ran-binding protein 2 (Ranbp2) unveils distinct physiological roles of its cyclophilin domain in proteostasis.

Authors:  Kyoung-in Cho; Hemangi Patil; Eugene Senda; Jessica Wang; Haiqing Yi; Sunny Qiu; Dosuk Yoon; Minzhong Yu; Andrew Orry; Neal S Peachey; Paulo A Ferreira
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

2.  Variable clinical course in acute necrotizing encephalopathy and identification of a novel RANBP2 mutation.

Authors:  Katharina Sell; Katja Storch; Gabriele Hahn; Min Ae Lee-Kirsch; Georgia Ramantani; Sandra Jackson; Derek Neilson; Maja von der Hagen; Ute Hehr; Martin Smitka
Journal:  Brain Dev       Date:  2016-02-26       Impact factor: 1.961

3.  H1N1 triggered recurrent acute necrotizing encephalopathy in a family with a T653I mutation in the RANBP2 gene.

Authors:  Geetha Anand; Ravindran Visagan; Saleel Chandratre; Shelley Segal; Andrea H Nemeth; Waney Squier; Fintan Sheerin; Derek Neilson; Sandeep Jayawant
Journal:  Pediatr Infect Dis J       Date:  2015-03       Impact factor: 2.129

4.  Familial Acute Necrotizing Encephalopathy: Evidence From Next Generation Sequencing of Digenic Inheritance.

Authors:  Gayatri Iyer; Prashant Utage; Sarah Bailur; Aparna Utage; Annapurna Srirambhatla; Qurratulain Hasan
Journal:  J Child Neurol       Date:  2020-02-26       Impact factor: 1.987

5.  Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2.

Authors:  Derek E Neilson; Mark D Adams; Caitlin M D Orr; Deborah K Schelling; Robert M Eiben; Douglas S Kerr; Jane Anderson; Alexander G Bassuk; Ann M Bye; Anne-Marie Childs; Antonia Clarke; Yanick J Crow; Maja Di Rocco; Christian Dohna-Schwake; Gregor Dueckers; Alfonso E Fasano; Artemis D Gika; Dimitris Gionnis; Mark P Gorman; Padraic J Grattan-Smith; Annette Hackenberg; Alice Kuster; Markus G Lentschig; Eduardo Lopez-Laso; Elysa J Marco; Sotiria Mastroyianni; Julie Perrier; Thomas Schmitt-Mechelke; Serenella Servidei; Angeliki Skardoutsou; Peter Uldall; Marjo S van der Knaap; Karrie C Goglin; David L Tefft; Cristin Aubin; Philip de Jager; David Hafler; Matthew L Warman
Journal:  Am J Hum Genet       Date:  2009-01       Impact factor: 11.025

6.  Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions.

Authors:  M Mizuguchi; J Abe; K Mikkaichi; S Noma; K Yoshida; T Yamanaka; S Kamoshita
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154

Review 7.  Genetic Acute Necrotizing Encephalopathy Associated with RANBP2: Clinical and Therapeutic Implications in Pediatrics.

Authors:  Jesse M Levine; Nusrat Ahsan; Eugenia Ho; Jonathan D Santoro
Journal:  Mult Scler Relat Disord       Date:  2020-05-15       Impact factor: 4.339

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.